Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience-Reference-Cited by-同舟云学术

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

Published:1999-08 Issue:1-2 Volume:18 Page:181-189
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pittman Phillip R.,Liu C.T.,Cannon Timothy L.,Makuch Richard S.,Mangiafico Joseph A.,Gibbs Paul H.,Peters Clarence J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference46 articles.

1. Rift Valley fever;Swanepoel,1994

2. Peters CJ, Linthicum KJ. Rift Valley fever. In: Baran GW, editor. Viral Zoonoses, 2nd ed. Handbook series of Zoonoses, Section B. Boca Raton, FL: CRC Press, 1994. p. 125

3. Pathogenesis of viral hemorrhagic fever: Rift Valley fever and Lassa fever contrasted;Peters;Rev. Infect. Dis.,1989

4. Meegan JM, Bailey CL. Rift Valley fever. In: Monath TP, editor. The arboviruses: epidemiology and ecology, Vol. 4. Boca Raton, FL: CRC Press, 1988. p. 51

5. Rift Valley fever epizootic in the central highlands of Madagascar;Morvan;Res. Virol.,1992

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice;Emerging Microbes & Infections;2024-07-10

2. Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial;The Lancet Infectious Diseases;2024-07

3. Rift Valley Fever in Travellers;Emerging and Re-emerging Infections in Travellers;2024

4. Arbovirus Infections;Manson's Tropical Diseases;2024

5. Humoral immunity to phlebovirus infection;Annals of the New York Academy of Sciences;2023-11-07